- Home
- » IRAC
- » Work Groups
IRAC Work Groups FY2010
- Work Group Descriptions
- Nanotechnology and Risk Assessment Work Group (N)
- Susceptible Populations Workgroup (S)
- Work Groups from Previous Years
*denotes IRAC representative
Work Groups
Nanotechnology and Risk Assessment Work Group (N)
- Dearfield, Kerry
- Kerry.Dearfield@fsis.usda.gov
- Dewan, Kapal
- kapal.dewan@fda.hhs.gov
- Flari, Villie
- Villie.flari@fda.hhs.gov
- Gwinn, Maureen
- Gwinn.Maureen@epamail.epa.gov
- Hyoung, Lee
- Lee.hyoung@fda.hhs.gov
- Lange, Rachel
- Rachel.lange@fda.hhs.gov
- Miliotis, Marianne
- Marianna.miliotis@fda.hhs.gov
- Pena, Carlos
- Carlos.pena@fda.hhs.gov
- Rua, Diego
- Diego.rua@fda.hhs.gov
- Smegal, Deborah
- smegal.deborah@epamail.epa.gov
- Treye, Thomas
- tthomas@cpsc.gov
- Thurmond, Scott
- Scott.thurmond@fda.hhs.gov
- Torrence, Mary
- mary.torrence@ars.usda.gov
Susceptible Populations Workgroup (S)
- Steven Gendel (FDA)
- Andrew Maccabe (CDC)
- Fred Angulo (CDC)
- Rebecca Brown (EPA)
- Kerry Dearfield (USDA)
- Janell Kause (USDA)
- Heejeong Latimer (USDA)
- Morrie Potter (FDA)
- Stephen Schaub (EPA)
- Debbie Smegal (EPA)
- Marian Olsen (EPA)
- Sherri Dennis (FDA)
- Manashi Dey (FDA)
- Stephanie Briguglio (FDA)
- Regis Pouillot (FDA)
- Mary Brandt (FDA)

